Komori
SK-Electronics (6677) · FactRestated

Continuation of Research and Development Activities

First written in FY2016-Q3. 22 of 28 entries say "Restated". Latest entry: FY2026-H1.

28entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2018-Q3RestatedFY2021-Q1 – FY2024-Q22016: 220162017: 320172018: 420182019: 420192020: 320202021: 420212022: 220222023: 320232024: 120242025: 120252026: 1
Same theme, other companies
Decline in R&D Expenses with No Change in Activity StatusA theme 44 companies write about · 18 as a headwind · 10 as a tailwind

8 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 44 companies compared. The sentences above are computed from all 44.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period. Total research and development expenses for the interim consolidated accounting period were ¥113 million, with the breakdown by segment as follows:」

    The statement that there were no material changes in research and development activities continued, and research and development expenses were ¥113 million. Expenses comprised ¥79 million for the large photomask business, ¥23 million for the solutions business, and ¥10 million for the screen mask and metal mask business.
  2. FY2025AdvancedAnnual report

    「Amid demand for higher definition and advanced functionality, including lower power consumption and foldable designs, in flat-panel displays, the Company developed photomasks with improved precision and photomasks compatible with state-of-the-art exposure equipment. In addition, it worked to improve price competitiveness and its ability to meet delivery deadlines.」

    The Company continued its research and development in improving precision, ensuring compatibility with state-of-the-art exposure equipment, and improving price competitiveness and its ability to meet delivery deadlines. Research and development expenses were ¥235 million.
  3. FY2024-Q2RestatedAnnual report

    「There were no material changes in the status of the Group's research and development activities during the six-month period of the current consolidated fiscal year. Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥113 million, with the breakdown by segment as follows:」

    It was stated that there were no material changes in research and development activities, while research and development expenses of ¥113 million were recorded.
  4. FY2023-Q3RestatedAnnual report

    「There were no material changes in the status of the Group's research and development activities during the nine-month period of the current consolidated fiscal year. Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥148 million, with the breakdown by segment as follows:」

    It was stated that there were no material changes in research and development activities, while research and development expenses of ¥148 million were recorded.
  5. FY2023-Q2RestatedAnnual report

    「There were no material changes in the status of the Group's research and development activities during the six-month period of the current consolidated fiscal year. Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥112 million, with the breakdown by segment as follows:」

    It was stated that there were no material changes in research and development activities, while research and development expenses of ¥112 million were recorded.
  6. FY2023-Q1RestatedAnnual report

    「There were no material changes in the status of the Group's research and development activities during the three-month period of the current consolidated fiscal year. Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥73 million, with the breakdown by segment as follows:」

    It was stated that there were no material changes in research and development activities, while research and development expenses of ¥73 million were recorded.
  7. FY2022-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥135 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥135 million, and it was stated that there were no material changes in the status of research and development activities.
  8. FY2022-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥45 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the current consolidated fiscal year.」

    Research and development expenses of ¥45 million were recorded, and it was stated that there were no material changes in the status of research and development activities.
  9. FY2021RestatedAnnual report

    「Amid demand for higher definition, lower power consumption and advanced functionality, including foldable designs, in OLED panels for smartphones, the Group developed photomasks with improved precision and photomasks compatible with state-of-the-art exposure equipment. In addition, it worked to improve price competitiveness and its ability to meet delivery deadlines.」

    The Group continues its research and development themes of improving the precision of photomasks for OLED applications, ensuring compatibility with state-of-the-art exposure equipment, and improving price competitiveness and its ability to meet delivery deadlines.
  10. FY2021-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥134 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the current consolidated fiscal year.」

    Research and development expenses of ¥134 million were recorded, and it was stated that there were no material changes in the status of research and development activities.
  11. FY2021-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥84 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the current consolidated fiscal year.」

    Research and development expenses of ¥84 million were recorded, and it was stated that there were no material changes in the status of research and development activities.
  12. FY2021-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥39 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the current consolidated fiscal year.」

    Research and development expenses of ¥39 million were recorded, and it was stated that there were no material changes in the status of research and development activities.
  13. FY2020AdvancedAnnual report

    「The Company developed photomasks for OLED applications with improved precision and new photomasks compatible with state-of-the-art exposure equipment. In addition, it worked to improve production-line efficiency to enhance price competitiveness and its ability to meet delivery deadlines.」

    The research and development themes became more specific, covering improved precision in OLED masks, compatibility with state-of-the-art exposure equipment, new photomasks and production-line efficiency. Research and development expenses were ¥337 million.
  14. FY2020-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥235 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the current consolidated fiscal year.」

    It was stated that there were no material changes in research and development activities, and research and development expenses were ¥235 million.
  15. FY2020-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥177 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥177 million, and it was stated that there were no material changes in the status of research and development activities.
  16. FY2019AdvancedAnnual report

    「Amid increasingly strong market demand for higher definition, precision and shorter lead times in flat-panel televisions, where larger displays and 4K and 8K resolution are advancing, smartphones, where the shift to OLED is accelerating, and VR and AR devices, which require ultra-high definition, the Group focused on advancing production technologies, creating advanced technologies originating in Japan, developing ultra-high-definition photomasks and building next-generation production lines, while also developing high-function photomasks compatible with state-of-the-art exposure equipment.」

    The research and development themes became more specific, covering advances in production technologies, advanced technologies originating in Japan, ultra-high-definition photomasks, next-generation production lines and compatibility with state-of-the-art exposure equipment. Research and development expenses were ¥392 million.
  17. FY2019-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥282 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥282 million, and it was stated that there were no material changes in the status of research and development activities.
  18. FY2019-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥206 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥206 million, and it was stated that there were no material changes in the status of research and development activities.
  19. FY2019-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥86 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥86 million, and it was stated that there were no material changes in the status of research and development activities.
  20. FY2018AdvancedAnnual report

    「Amid increasingly strong market demand for higher definition and precision in flat-panel televisions, where larger displays and 4K and 8K resolution are advancing, smartphones, where higher definition and a shift to OLED are progressing, and VR and AR devices, which require ultra-high definition, the Group focused on developing microfabrication and high-precision technologies, while also developing high-value-added photomasks with improved exposure performance.」

    Research and development expanded to 4K, 8K, VR and AR, and research and development expenses for the fiscal year were ¥407 million.
  21. FY2018-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥303 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥303 million, and it was stated that there were no material changes in the status of research and development activities.
  22. FY2018-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥206 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥206 million, and it was stated that there were no material changes in the status of research and development activities.
  23. FY2018-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥126 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥126 million, and it was stated that there were no material changes in the status of research and development activities.
  24. FY2017-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥357 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥357 million, and it was stated that there were no material changes in the status of research and development activities.
  25. FY2017-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥227 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥227 million, and it was stated that there were no material changes in the status of research and development activities.
  26. FY2017-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥131 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥131 million, and it was stated that there were no material changes in the status of research and development activities.
  27. FY2016AdvancedAnnual report

    「Amid growing demand for higher definition and precision in LCD televisions, where larger display sizes and 4K resolution are advancing, and smartphones, where higher definition and a shift to OLED are progressing, the Group focused on developing microfabrication and high-precision technologies, while also developing high-value-added photomasks with improved exposure performance.」

    Full-year research and development expenses were ¥417 million, and specific development themes, including microfabrication, high-precision technologies and high-value-added photomasks, were described.
  28. FY2016-Q3First statedAnnual report

    「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥296 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the current consolidated fiscal year.」

    Research and development expenses were ¥296 million, and it was stated that there were no material changes in the status of research and development activities.
Moved together

"Expansion of large photomask production capacity and investment in higher resolution" moved the same way as this thread, in the same document, in 4 of its 28 moves.

433333★123456
  1. ★This thread
  2. 1Expansion of large photomask production capacity and investment in higher resolution4×
  3. 2Progress in OLED and Large-Format LCD Panel Investment3×
  4. 3Demand for Gen 8 and below, Gen 6, and high-value-added photomasks3×
  5. 4Declining revenue and profit, with profit attributable to owners of the parent broadly flat3×
  6. 5Early Commercialization of Ultra-Small RFID3×
  7. 6Expansion of healthcare product sales and development of proprietary products3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for SK-Electronics yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.